1. Home
  2. GUG vs LXRX Comparison

GUG vs LXRX Comparison

Compare GUG & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guggenheim Active Allocation Fund of Beneficial Interest

GUG

Guggenheim Active Allocation Fund of Beneficial Interest

HOLD

Current Price

$15.72

Market Cap

499.6M

Sector

Finance

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.86

Market Cap

660.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GUG
LXRX
Founded
N/A
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
499.6M
660.9M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
GUG
LXRX
Price
$15.72
$1.86
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.15
AVG Volume (30 Days)
77.1K
2.2M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
60.24
52 Week Low
$14.24
$0.49
52 Week High
$16.50
$1.84

Technical Indicators

Market Signals
Indicator
GUG
LXRX
Relative Strength Index (RSI) 57.60 64.34
Support Level $15.38 $1.07
Resistance Level $15.77 N/A
Average True Range (ATR) 0.30 0.10
MACD 0.09 0.01
Stochastic Oscillator 76.26 98.61

Price Performance

Historical Comparison
GUG
LXRX

About GUG Guggenheim Active Allocation Fund of Beneficial Interest

Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: